Department of Medicine, University of Otago, Christchurch, New Zealand.
Department of Clinical Pharmacology, Canterbury District Health Board, Canterbury, New Zealand.
Br J Clin Pharmacol. 2023 Oct;89(10):3105-3115. doi: 10.1111/bcp.15814. Epub 2023 Jun 22.
The UK Prescribing Safety Assessment was modified for use in Australia and New Zealand (ANZ) as the Prescribing Skills Assessment (PSA). We investigated the implementation, student performance and acceptability of the ANZ PSA for final-year medical students.
This study used a mixed-method approach involving student data (n = 6440) for 2017-2019 (PSA overall score and 8 domain subscores). Data were also aggregated by medical school and included student evaluation survey results. Quantitative data were analysed using descriptive and multivariate analyses. The pass rate was established by a modified Angoff method. Thematic analyses of open-ended survey comments were conducted.
The average pass rate was slightly higher in 2017 (89%) which used a different examination to 2018 (85%) and 2019 (86%). Little difference was identified between schools for the PSA overall performance or domain subscores. There was low intercorrelation between subscores. Most students provided positive feedback about the PSA regarding the interface and clarity of questions, but an average of 35% reported insufficient time for completion. Further, 70% on average felt unprepared by their school curricula for the PSA, which is in part explained by the low prescribing experience; 69% reported completing ≤10 prescriptions during training.
The ANZ PSA was associated with high pass rates and acceptability, although student preparedness was highlighted as a concern for further investigation. We demonstrate how a collaboration of medical schools can adapt a medical education assessment resource (UK PSA) as a means for fulfilling an unmet need.
英国处方安全评估(UK Prescribing Safety Assessment)经过修改,在澳大利亚和新西兰(Australia and New Zealand,ANZ)被用作处方技能评估(Prescribing Skills Assessment,PSA)。我们调查了针对医学专业最后一年学生的 ANZ PSA 的实施情况、学生表现和可接受性。
本研究采用混合方法,包括 2017-2019 年学生数据(n=6440),包括 PSA 总体得分和 8 个领域子得分。数据还按医学院进行了汇总,并包括学生评估调查结果。使用描述性和多元分析对定量数据进行分析。通过率采用改良的 Angoff 法确定。对开放式调查评论进行了主题分析。
2017 年(89%)的平均通过率略高于 2018 年(85%)和 2019 年(86%),当时使用了不同的考试。各学校之间在 PSA 总体表现或领域子得分方面没有明显差异。子得分之间相关性较低。大多数学生对 PSA 的界面和问题的清晰度给予了积极的反馈,但平均有 35%的学生报告完成时间不足。此外,平均有 70%的学生认为他们的学校课程对 PSA 的准备不足,这在一定程度上是由于处方经验不足造成的;69%的学生报告在培训期间完成的处方数≤10。
ANZ PSA 与高通过率和可接受性相关,尽管学生的准备情况被强调为进一步调查的关注点。我们展示了医学学校的合作如何能够改编医学教育评估资源(英国 PSA),以满足未满足的需求。